These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34666796)
41. Hepatic features of Wilson disease. Boga S; Ala A; Schilsky ML Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114 [TBL] [Abstract][Full Text] [Related]
42. Structural and functional brain changes in hepatic and neurological Wilson disease. Tinaz S; Arora J; Nalamada K; Vives-Rodriguez A; Sezgin M; Robakis D; Patel A; Constable RT; Schilsky ML Brain Imaging Behav; 2021 Oct; 15(5):2269-2282. PubMed ID: 33244627 [TBL] [Abstract][Full Text] [Related]
43. Observation on the changes of clinical symptoms, blood and brain copper deposition in Wilson disease patients treated with dimercaptosuccinic acid for 2 years. Zhou XX; Pu XY; Xiao X; Chen DB; Wu C; Li XH; Liang XL J Clin Neurosci; 2020 Nov; 81():448-454. PubMed ID: 33222961 [TBL] [Abstract][Full Text] [Related]
44. Cognitive impairment in stable Wilson disease across phenotype. Kirk FT; Munk DE; Laursen TL; Vilstrup H; Ott P; Grønbæk H; Lauridsen MM; Sandahl TD Metab Brain Dis; 2021 Oct; 36(7):2173-2177. PubMed ID: 34342812 [TBL] [Abstract][Full Text] [Related]
45. The Patient Experience with Diabetic Retinopathy: Qualitative Analysis of Patients with Proliferative Diabetic Retinopathy. Sherman SA; Rofail D; Levine A; Hartford CR; Baldasaro J; Marquis P; Rao R; Do DV Ophthalmol Ther; 2023 Feb; 12(1):431-446. PubMed ID: 36460939 [TBL] [Abstract][Full Text] [Related]
46. Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study. Altman DE; Zhang X; Fu AC; Rams AR; Baldasaro JA; Ahmad SA; Schlichting M; Marquis P; Benincasa E; Moulin C; Pawar V Oncol Ther; 2023 Jun; 11(2):231-244. PubMed ID: 36800099 [TBL] [Abstract][Full Text] [Related]
47. Hypersomnolence in Wilson Disease. Amann VC; Maru NK; Jain V J Clin Sleep Med; 2015 Nov; 11(11):1341-3. PubMed ID: 25902827 [TBL] [Abstract][Full Text] [Related]
48. Wilson disease and psychiatric symptoms: A brief case report. Guerrero-Jiménez M; Carrillo de Albornoz Calahorro CM; Gutierrez Rojas L Gen Psychiatr; 2019; 32(3):e100066. PubMed ID: 31423476 [TBL] [Abstract][Full Text] [Related]
49. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge! Srinivas K; Sinha S; Taly AB; Prashanth LK; Arunodaya GR; Janardhana Reddy YC; Khanna S J Neurol Sci; 2008 Mar; 266(1-2):104-8. PubMed ID: 17904160 [TBL] [Abstract][Full Text] [Related]
50. Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and Germany. Hall R; Trennery C; Chan R; Gater A; Bradley H; Sikirica MV; von Maltzahn R; Sousa AR; Nelsen LM Value Health; 2020 May; 23(5):632-641. PubMed ID: 32389229 [TBL] [Abstract][Full Text] [Related]
51. Efficacy of Different Diagnostic Test for Identifying Wilson's Disease. Sonia ZF; Rukunuzzaman M; Karim MB; Yasmin A; Alam R Mymensingh Med J; 2022 Jan; 31(1):117-123. PubMed ID: 34999690 [TBL] [Abstract][Full Text] [Related]
52. Cardiac involvement in Wilson disease: Review of the literature and description of three cases of sudden death. Chevalier K; Benyounes N; Obadia MA; Van Der Vynckt C; Morvan E; Tibi T; Poujois A J Inherit Metab Dis; 2021 Sep; 44(5):1099-1112. PubMed ID: 34286869 [TBL] [Abstract][Full Text] [Related]
53. Misidentification of Wilson Disease as Schizophrenia (1998-2013): Case Report and Review. Elyasi F Indian J Psychol Med; 2017; 39(5):675-681. PubMed ID: 29200569 [TBL] [Abstract][Full Text] [Related]
54. Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. Bruha R; Vitek L; Marecek Z; Pospisilova L; Nevsimalova S; Martasek P; Petrtyl J; Urbanek P; Jiraskova A; Malikova I; Haluzik M; Ferenci P J Inherit Metab Dis; 2012 May; 35(3):541-8. PubMed ID: 22139496 [TBL] [Abstract][Full Text] [Related]
55. Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings. Galipeau N; Klooster B; Krohe M; Tang DH; Revicki DA; Cella D J Patient Rep Outcomes; 2019 Feb; 3(1):10. PubMed ID: 30734110 [TBL] [Abstract][Full Text] [Related]
56. [Wilson disease: an update]. Seo JK Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287 [TBL] [Abstract][Full Text] [Related]
57. Disturbed copper transport in humans. Part 2: mutations of the ATP7B gene lead to Wilson disease (WD). Seidel J; Caca K; Schwab SG; Berr F; Wildenauer DB; Mentzel HJ; Horn N; Kauf E Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL149-57. PubMed ID: 11936861 [TBL] [Abstract][Full Text] [Related]
58. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. Mordaunt CE; Kieffer DA; Shibata NM; Członkowska A; Litwin T; Weiss KH; Zhu Y; Bowlus CL; Sarkar S; Cooper S; Wan YY; Ali MR; LaSalle JM; Medici V Epigenetics Chromatin; 2019 Feb; 12(1):10. PubMed ID: 30709419 [TBL] [Abstract][Full Text] [Related]
59. A novel COMMD1 mutation Thr174Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient. Gupta A; Chattopadhyay I; Mukherjee S; Sengupta M; Das SK; Ray K Behav Brain Funct; 2010 Jun; 6():33. PubMed ID: 20550661 [TBL] [Abstract][Full Text] [Related]
60. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire. Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]